Patel Jeegar Pravinkumar
Chief Scientific Officer
Patel Jeegar Pravinkumar has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Jun 25, 2026.
On the most recent filing, Patel Jeegar Pravinkumar is listed as Chief Scientific Officer at Evommune, Inc. Inside the rolling window, Patel Jeegar Pravinkumar reported no open-market purchases and 2 open-market sales totaling $413K in EVMN. The largest disclosed transaction in the window is a sale of 16,687 EVMN shares on Jun 1, 2026, worth $379K.
Companies traded
Other insiders at EVMN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$413K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Patel Jeegar Pravinkumar made?
Patel Jeegar Pravinkumar has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Patel Jeegar Pravinkumar trade?
Patel Jeegar Pravinkumar has filed SEC Form 4 disclosures for 1 company, including EVMN.
When was Patel Jeegar Pravinkumar's most recent SEC Form 4 filing?
Patel Jeegar Pravinkumar's most recent SEC Form 4 filing on Tracefour is dated Jun 25, 2026.
What is Patel Jeegar Pravinkumar's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Patel Jeegar Pravinkumar is listed as Chief Scientific Officer.
What is Patel Jeegar Pravinkumar's total buy and sell value in the current window?
Inside the rolling retention window, Patel Jeegar Pravinkumar bought $0 and sold $413K based on SEC Form 4 filings.
What was Patel Jeegar Pravinkumar's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 16,687 EVMN shares on 2026-06-01, worth $379K, per SEC Form 4 filings.